“Global Clinical Trial Supply and Logistics market for pharma set to grow to $26bn by 2024” says new Visiongain report18 April 2019Pharma
Emerging markets offer many benefits for companies looking to conduct clinical trials, including large patient population and lower trial costs.
17 April 2019Pharma
The biosimilars landscape will likely to undergo great changes in the future as the market starts to mature.
16 April 2019Pharma
A major restraint in the global drug discovery outsourcing market comes from the fact that it is quickly becoming saturated, with many contract research organisations offering poorly differentiated services.
15 April 2019Pharma
The dermatological drugs market has in the past been the domain of small and medium-sized pharma companies specialising in dermatology and perhaps a few other therapeutic areas.
11 April 2019Pharma
Chemotherapy will continue to be the largest segment for therapy of cancer; however, the huge effort for a breakthrough in cancer treatment will result in the growth of targeted cell therapy as well as immunotherapy segments.